Gilig, Rocky Shann M.
HRN: 25-84-89 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/21/2025
03/27/2025
IVT
550mg
Q6
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes